• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    RLX Technology's MSCI ESG Rating Upgraded to "AA", Achieving the Highest Rating in the Global Tobacco Industry

    12/30/24 4:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $RLX alert in real time by email

    SHENZHEN, China, Dec. 30, 2024 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, has recently achieved an "AA" rating in the MSCI ESG rating, upgraded from an "A" rating. RLX Technology has secured the top position in the global e-cigarette industry for three consecutive years and has achieved the highest MSCI ESG rating in the global tobacco industry.

    RLX Technology's MSCI ESG Rating Upgraded to "AA"

    MSCI ESG ratings aim to measure a company's management of financially relevant ESG risks and opportunities and rate over 8,500 companies every year. MSCI ESG ratings have become a key reference for international capital market participants. The "AA" rating is a significant recognition of RLX Technology's ESG governance structure, further solidifying its leadership position in the e-vapor sector. The Company is also expected to gain increasing opportunities for inclusion in various fund portfolios or gain larger asset allocations.

    Ms. Ying (Kate) Wang, Co-founder, Chairperson of the Board of Directors, and Chief Executive Officer of RLX Technology, stated, "We understand that corporate success lies not only in operational profitability, but also in social and environmental responsibility. The Company has focused on optimizing its product portfolio, supply chains, and operations to enhance corporate value while positively impacting society and the environment."

    According to MSCI, RLX ranks best-in-class for risk management capabilities in product safety, quality, and chemical safety. It also ranks among the top 1% globally in risk management for accounting, business ethics, and tax transparency. Regarding supply chain labor standards, all assessments have met MSCI's "Top" standards.

    Since its inception, RLX Technology has integrated ESG in its corporate strategy to foster sustainable development. Following the implementation of national e-cigarettes standards and regulations in China, RLX Technology fully upgraded its R&D system, establishing eight laboratories and implementing stringent factory quality controls. This significantly enhanced product innovation capabilities and established a comprehensive product quality assurance system throughout the product lifecycle.

    The RLX Technology quality and safety laboratory was recognized by CNAS (China National Accreditation Service For Conformity Assessment) in July 2023 and passed expansion and modification assessment in June 2024. Currently, RLX Technology has established a comprehensive testing platform that can provide reliability, electrical performance, inhalation testing, and battery safety testing services for the e-vapor industry, and issue authoritative reports for export products according to international standards.

    Furthermore, the Company maintains strict internal standards, incorporating ESG criteria into its supplier selection process. RLX Technology annually conducts ESG assessments of its core suppliers, performing external audits based on the "RLX Business Partner Code of Conduct", SA8000 standards, and other ESG-related metrics.

    RLX Technology has always regarded ESG as one of its core competitive edges. It established an ESG committee at the Board level and has published ESG reports for four consecutive years. TÜV Rheinland, a leading international verification agency, has independently verified the report in 2022 and 2023 according to the AA1000 Assurance Standard v3, ensuring the accuracy and credibility of the substantive issues addressed.

    Looking ahead, RLX remains committed to steadfastly implementing its long-term ESG strategy, actively fulfilling its corporate social responsibilities, and continuously creating greater value for clients, shareholders, partners, employees, and society.

    About RLX Technology Inc.

    RLX Technology Inc. (NYSE:RLX) is a leading global branded e-vapor company. The Company leverages its strong in-house technology, product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products.

    For more information, please visit: http://ir.relxtech.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/rlx-technologys-msci-esg-rating-upgraded-to-aa-achieving-the-highest-rating-in-the-global-tobacco-industry-302340109.html

    SOURCE RLX Technology Inc.

    Get the next $RLX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RLX

    DatePrice TargetRatingAnalyst
    3/17/2025$2.80 → $2.50Buy → Neutral
    Citigroup
    8/8/2023$2.60Buy
    UBS
    More analyst ratings

    $RLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RLX Technology Announces Unaudited Second Quarter 2025 Financial Results

    SHENZHEN, China, Aug. 22, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024.Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.U.S

    8/22/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology to Report Second Quarter 2025 Financial Results on August 22, 2025

    - Earnings Call Scheduled for 8:00 a.m. ET on August 22, 2025 - SHENZHEN, China, Aug. 5, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before the U.S. markets open on Friday, August 22, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on August 22, 2025 (8:00 PM Beijing/Hong Kong Time on August 22, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Ko

    8/5/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology Announces Unaudited First Quarter 2025 Financial Results

    SHENZHEN, China, May 16, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024.Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024.U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.Non-GAAP net income[1

    5/16/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RLX Technology downgraded by Citigroup with a new price target

    Citigroup downgraded RLX Technology from Buy to Neutral and set a new price target of $2.50 from $2.80 previously

    3/17/25 7:42:34 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    UBS initiated coverage on RLX Technology with a new price target

    UBS initiated coverage of RLX Technology with a rating of Buy and set a new price target of $2.60

    8/8/23 9:12:45 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    SEC Filings

    View All

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    8/22/25 7:09:03 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    5/16/25 6:02:23 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 20-F filed by RLX Technology Inc.

    20-F - RLX Technology Inc. (0001828365) (Filer)

    4/17/25 4:01:47 PM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Financials

    Live finance-specific insights

    View All

    RLX Technology Announces Unaudited Second Quarter 2025 Financial Results

    SHENZHEN, China, Aug. 22, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024.Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.U.S

    8/22/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology to Report Second Quarter 2025 Financial Results on August 22, 2025

    - Earnings Call Scheduled for 8:00 a.m. ET on August 22, 2025 - SHENZHEN, China, Aug. 5, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before the U.S. markets open on Friday, August 22, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on August 22, 2025 (8:00 PM Beijing/Hong Kong Time on August 22, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Ko

    8/5/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology Announces Unaudited First Quarter 2025 Financial Results

    SHENZHEN, China, May 16, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024.Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024.U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.Non-GAAP net income[1

    5/16/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/7/24 6:06:29 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/6/24 4:01:28 PM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/14/23 6:01:42 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care